Shapiro Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,325,733
Closed -$50.5M 87
2017
Q1
$50.5M Sell
1,325,733
-165,475
-11% -$6.45M 1.21% 34
2016
Q4
$55.1M Sell
1,491,208
-60,975
-4% -$2.18M 1.41% 32
2016
Q3
$53.8M Sell
1,552,183
-1,799,926
-54% -$63M 1.43% 32
2016
Q2
$109M Sell
3,352,109
-1,673,941
-33% -$51.3M 3.03% 12
2016
Q1
$144M Buy
5,026,050
+1,368,787
+37% +$36.5M 4.18% 6
2015
Q4
$122M Buy
3,657,263
+550,997
+18% +$17.1M 3.57% 8
2015
Q3
$88.3M Buy
+3,106,266
New +$108M 2.65% 16

Other funds holding AVNS

Shapiro Capital Management's AVNS Position: Q2 2017 in Review

Shapiro Capital Management sold out of Avanos Medical (AVNS) in Q2 2017, closing a stake of 1,325,733 shares — an estimated $50.5M sold.

Shapiro Capital Management first reported a position in AVNS in Q3 2015 and held it in 7 quarters. The position peaked at $144M in Q1 2016. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

  • Shapiro Capital Management reported no remaining Avanos Medical position as of Q2 2017 after selling out during the quarter.
  • Shapiro Capital Management sold 1,325,733 Avanos Medical shares in Q2 2017, an estimated $50.5M.
  • Shapiro Capital Management first reported a position in Avanos Medical in Q3 2015 and held it in 7 quarters.
  • Shapiro Capital Management's Avanos Medical position peaked at $144M in Q1 2016.
  • 328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Shapiro Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.